Abbott Laboratories
XMUN:ABL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Abbott Laboratories
XMUN:ABL
|
US |
|
M
|
Mitsubishi Electric Corp
OTC:MIELY
|
JP |
|
L
|
Lagardere SA
DUS:LAG
|
FR |
|
Saipem SpA
F:SPE1
|
IT |
|
DFDS AS
F:29K
|
DK |
|
P
|
Pernod Ricard SA
XMUN:PER
|
FR |
Wall St Price Targets
ABL Price Targets Summary
Abbott Laboratories
According to Wall Street analysts, the average 1-year price target for ABL is 103.46 EUR with a low forecast of 79.6 EUR and a high forecast of 122.34 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ABL's stock price target?
Price Target
103.46
EUR
According to Wall Street analysts, the average 1-year price target for ABL is 103.46 EUR with a low forecast of 79.6 EUR and a high forecast of 122.34 EUR.
What is the Revenue forecast for Abbott Laboratories?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 3 years is 10%.
What is the Gross Profit forecast for Abbott Laboratories?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 7%. The projected CAGR for the next 3 years is 11%.
What is the Operating Income forecast for Abbott Laboratories?
Projected CAGR
20%
Over the last 13 years, the compound annual growth rate for Operating Income has been 15%. The projected CAGR for the next 3 years is 20%.
What is the Pre-Tax Income forecast for Abbott Laboratories?
Projected CAGR
19%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 19%.
What is the Net Income forecast for Abbott Laboratories?
Projected CAGR
22%
Over the last 13 years, the compound annual growth rate for Net Income has been 1%. The projected CAGR for the next 3 years is 22%.
